Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 11, 2026

Stereotactic Radiosurgery for Gynecologic Cancer
10:35

Stereotactic Radiosurgery for Gynecologic Cancer

Published on: April 17, 2012

[Cyberknife robotic stereotactic radiotherapy: technical aspects and recent developments].

J Thariat1, S Marcié, P-Y Marcy

  • 1Université Nice-Sophia-Antipolis, Centre Antoine-Lacassagne, Département d'oncologie-radiothérapie, IBDC CNRS UMR, France. jthariat@hotmail.com

Bulletin Du Cancer
|July 3, 2010
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sinonasal squamous cell carcinoma: REFCOR guidelines for diagnosis, treatment and follow-up.

European annals of otorhinolaryngology, head and neck diseases·2026
Same author

From operating room to radiotherapy planning: A technical innovation in sinonasal oncology.

European annals of otorhinolaryngology, head and neck diseases·2026
Same author

REFCOR guidelines for sinonasal adenocarcinoma.

European annals of otorhinolaryngology, head and neck diseases·2026
Same author

Sinonasal mucosal melanoma: REFCOR guidelines for diagnosis, treatment and follow-up.

European annals of otorhinolaryngology, head and neck diseases·2026
Same author

A review of clinical trial radiotherapy quality assurance: value, evolution and lessons.

Clinical and translational radiation oncology·2026
Same author

REFCOR good practice guidelines for radiotherapy in sinonasal carcinomas and mucosal melanomas.

European annals of otorhinolaryngology, head and neck diseases·2026

CyberKnife stereotactic body radiation therapy (SBRT) offers a novel cancer treatment using advanced technology. This approach shows promising local control and tolerance for early-stage and oligometastatic cancers, enhancing quality of life.

Area of Science:

  • Oncology
  • Radiation Oncology
  • Medical Physics

Background:

  • Stereotactic body radiation therapy (SBRT) is an advanced radiation technique.
  • CyberKnife is a robotic SBRT system known for its precision and advanced technology.

Purpose of the Study:

  • To describe the CyberKnife SBRT as a novel cancer treatment modality.
  • To highlight its applications in early-stage and oligometastatic cancer.
  • To discuss its potential for disease control and quality of life.

Main Methods:

  • Delivery of a small number of high doses of radiation to a target volume.
  • Utilizes continuously evolving advanced technology for precise targeting.
  • Employs strict quality assurance programs and prospective clinical evaluation.

More Related Videos

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy
08:17

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy

Published on: June 7, 2015

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

Related Experiment Videos

Last Updated: Jun 11, 2026

Stereotactic Radiosurgery for Gynecologic Cancer
10:35

Stereotactic Radiosurgery for Gynecologic Cancer

Published on: April 17, 2012

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy
08:17

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy

Published on: June 7, 2015

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

Main Results:

  • CyberKnife SBRT has emerged as a novel treatment modality for cancer.
  • It is indicated as an alternative to surgery for early-stage primary cancer.
  • Shows promising local control and tolerance, with increasing indications.
  • Optimizes disease control and quality of life for oligometastatic disease patients.

Conclusions:

  • CyberKnife SBRT modifies cancer treatment concepts with promising outcomes.
  • Despite radiobiology uncertainties in hypofractionation, results are encouraging.
  • Continued clinical evaluation and quality assurance are essential for expanding indications.